Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 1090.05
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. Its products include general medicines, B-Lactam, cephalosporins, anti-retroviral and veterinary medicines. The company was founded by Ramesh Desai on September 3, 1992 and is headquartered in Vadodara, India.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell